Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register	BMJ OPEN	2020
Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin	BIOCHEMICAL PHARMACOLOGY	2019
Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia	ANNALS OF THE AMERICAN THORACIC SOCIETY	2019
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY	2019
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices	CLINICAL RESEARCH IN CARDIOLOGY	2019
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review	JOURNAL OF ALZHEIMER'S DISEASE	2019
Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation. the west birmingham atrial fibrillation project	INTERNATIONAL JOURNAL OF CARDIOLOGY	2019
Tailored practical management of patients with atrial fibrillation. a risk factor-based approach	FRONTIERS IN CARDIOVASCULAR MEDICINE	2019
Update and unmet needs on the use of nonvitamin k Oral anticoagulants for stroke prevention in patients with atrial fibrillation	CURRENT PROBLEMS IN CARDIOLOGY	2019
Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. a systematic review and bayesian meta-regression analysis	AUTOIMMUNITY REVIEWS	2019
Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy	THROMBOSIS AND HAEMOSTASIS	2019
ABC (Atrial fibrillation Better Care) Pathway and Healthcare Costs in Atrial Fibrillation: The ATHERO-AF Study	THE AMERICAN JOURNAL OF MEDICINE	2019
A Simple Clinical Risk Score (C 2 HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects	CHEST	2019
Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation. a post-hoc analysis from the ATHERO-AF cohort	ATHEROSCLEROSIS	2019
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease	LIVER INTERNATIONAL	2019
Statins and non-alcoholic fatty liver disease	LIVER INTERNATIONAL	2019
Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?	WORLD JOURNAL OF GASTROENTEROLOGY	2019
Off-label use of ceftaroline fosamil: a systematic review	INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS	2019
Prevalence and Impact of Nonalcoholic Fatty Liver Disease in Atrial Fibrillation	MAYO CLINIC PROCEEDINGS	2019
Does the Coexistence of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation Affect Nox2 Activity and Urinary Isoprostanes Excretion?	ANTIOXIDANTS & REDOX SIGNALING	2019

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.